TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32873460

Group type: EXPERIMENTAL
Intervention: TAU + cognitive remediation
Number of subjects: 146

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 146
Study: 35630107

Group type: EXPERIMENTAL
Intervention: Remimazolam−remifentanil (RR) group
Number of subjects: 90

Group type: COMPARATOR
Intervention: Propofol−remifentanil (PR) group
Number of subjects: 90
Study: 34227314

Group type: EXPERIMENTAL
Intervention: Ensemble HQSAR model using DB‐210 stationary phase; FD set to 'donor/acceptor atoms (DA)' and FS set to 1-9.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ensemble HQSAR model using HP‐Innowax stationary phase; FD set to 'DA' and FS set to 4-7.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Individual HQSAR model using DB‐210 stationary phase.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Individual HQSAR model using HP‐Innowax stationary phase.
Number of subjects: 34
Study: 32802868

Group type: EXPERIMENTAL
Intervention: SL implants (implants with an augmented depth of the threads)
Number of subjects: 14

Group type: COMPARATOR
Intervention: SY implants (implants with standard threads)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Both SL and SY implants
Number of subjects: 14
Study: 35652298

Group type: EXPERIMENTAL
Intervention: Cast immobilization for 4 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cast immobilization for 6 weeks
Number of subjects: 50
Study: 32384160

Group type: EXPERIMENTAL
Intervention: Systemic patient-controlled analgesia (PCA) or regional analgesic techniques
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Pain intensity
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Prevalence of postoperative pain
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Quality of Recovery (QoR)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Organizational improvements
Number of subjects: 900
Study: 35970671

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block with 25 mL of bupivacaine plus 0.5 μg/kg of dexmedetomidine
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Erector spinae plane (ESP) block
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional intravenous analgesia with a 0.7 μg/kg dexmedetomidine bolus and a 0.3 μg/kg infusion
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional intravenous analgesia
Number of subjects: 130
Study: 34185376

Group type: EXPERIMENTAL
Intervention: Parent gesture training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 33260146

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beetroot juice (BR)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nitrate-depleted beetroot juice (PLA)
Number of subjects: 8
Study: 33025616

Group type: EXPERIMENTAL
Intervention: Fenugreek extract (FHE) 250 mg × 2/day for 42 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Fenugreek extract (FHE)
Number of subjects: 48
Study: 35470518

Group type: EXPERIMENTAL
Intervention: Wonders & Worries intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 60
Study: 33852919

Group type: EXPERIMENTAL
Intervention: Mycobacterium w (Mw) 0.3 mL/d intradermally for 3 days
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Mycobacterium w (Mw)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Mycobacterium w (Mw) and Placebo
Number of subjects: 202
Study: 33991552

Group type: EXPERIMENTAL
Intervention: Frova Intubating Catheter (IC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: McGrath Videolaryngoscope (VL)
Number of subjects: 49
Study: 33843705

Group type: EXPERIMENTAL
Intervention: Posture control training using a virtual reality (VR) program
Number of subjects: 20

Group type: COMPARATOR
Intervention: Arm reach training in the sitting position (Control)
Number of subjects: 20
Study: 35639720

Group type: EXPERIMENTAL
Intervention: Citicoline 1gm BD intravenously for three days, followed by oral citicoline 1gm BD for 39 days.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (100ml intravenous normal saline for three days, followed by multivitamin tablet BD for 39 days).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Citicoline
Number of subjects: 0
Study: 33559293

Group type: EXPERIMENTAL
Intervention: 3D convolutional neural network (3D CNN) model
Number of subjects: 237

Group type: COMPARATOR
Intervention: Manual segmentations of tumor by two radiologists
Number of subjects: 237
Study: 33147257

Group type: EXPERIMENTAL
Intervention: G-CSF post-ASCT
Number of subjects: 111

Group type: COMPARATOR
Intervention: Avoided G-CSF post-ASCT
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Avoided G-CSF and added corticosteroid prophylaxis post-ASCT
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: G-CSF avoidance plus corticosteroids
Number of subjects: 111
Study: 35380875

Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Ankle Bathing (AB)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control Condition (CON)
Number of subjects: 42
Study: 34266998

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) + Coronally advanced flap (CAF)
Number of subjects: 10

Group type: COMPARATOR
Intervention: De‐epithelialized connective tissue graft (DeCTG) + Coronally advanced flap (CAF)
Number of subjects: 10
Study: 33425825

Group type: EXPERIMENTAL
Intervention: wecoach web-application
Number of subjects: 0
Study: 36116756

Group type: EXPERIMENTAL
Intervention: Mindfulness-based resilience training (active intervention)
Number of subjects: 706

Group type: COMPARATOR
Intervention: Passive web-based psychoeducation about chronic stress and burnout (control)
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Mindfulness-based interventions (up to 3 sequential interventions based on non-response)
Number of subjects: 706
Study: 33751297

Group type: EXPERIMENTAL
Intervention: Immediate loading (Group A)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Early loading (Group B)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Overall (50 implants)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Comparison of radiographic bone levels
Number of subjects: 42
Study: 35508680

Group type: COMPARATOR
Intervention: DBS switched off (STIM OFF)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Omnidirectional stimulation with 60 µs (oDBS60)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Omnidirectional stimulation with 30 µs (oDBS30)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Directional stimulation at the best segment with 60 µs (dDBS60)
Number of subjects: 13
Study: 36384755

Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy (CCRT)
Number of subjects: 298
Study: 32134114

Group type: EXPERIMENTAL
Intervention: Live attenuated hepatitis A virus vaccine (HA‐L)
Number of subjects: 1297
Study: 36093705

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 46
Study: 34838132

Group type: EXPERIMENTAL
Intervention: Intravenous thyroxine for at least 12 hours
Number of subjects: 800

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 800
Study: 32424949

Group type: EXPERIMENTAL
Intervention: Xylazine continuous rate infusion (CRI) at 1 mg/kg/hr for 2, 4, and 6 hours after an initial bolus of 0.5 mg/kg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Xylazine continuous rate infusion (CRI)
Number of subjects: 0
Study: 35260787

Group type: EXPERIMENTAL
Intervention: tolcapone (COMT inhibitor)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 33001210

Group type: EXPERIMENTAL
Intervention: Atropine, 0.01%
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 35468752

Group type: EXPERIMENTAL
Intervention: Contoura treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Custom‐Q treatment
Number of subjects: 30
Study: 33531449

Group type: EXPERIMENTAL
Intervention: NaOCl gel
Number of subjects: 52

Group type: COMPARATOR
Intervention: NaOCl solution
Number of subjects: 52
Study: 34241629

Group type: EXPERIMENTAL
Intervention: Apatinib (500 mg orally once daily on days 1 to 21) plus SOX (S‐1: 40‐60 mg orally twice daily on days 1 to 14; oxaliplatin: 130 mg/m2 intravenously on day 1) every 3 weeks for 2 to 5 cycles
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Apatinib plus SOX
Number of subjects: 48
Study: 32445850

Group type: EXPERIMENTAL
Intervention: Vapocoolant spray
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 63
Study: 35075738

Group type: EXPERIMENTAL
Intervention: Trauma-Informed Guilt Reduction (TrIGR)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Supportive Care Therapy (SCT)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 145
Study: 34925003

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) prescriptions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-dose group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low-dose group
Number of subjects: 0
Study: 32127340

Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 35492074

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine + Ketamine (Mor + Ket)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32731825

Group type: COMPARATOR
Intervention: Cemented TKA
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cementless 3D-printed TKA
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cementless TKA
Number of subjects: 72
Study: 35496368

Group type: EXPERIMENTAL
Intervention: Lidocaine (1.5 mg/kg bolus completed 10 min before anesthesia induction followed by an infusion at 2.0 mg/kg/h)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (volume-matched at the same infusion rate)
Number of subjects: 60
Study: 32105678

Group type: EXPERIMENTAL
Intervention: Valaciclovir (8 g/d) given from the diagnosis of primary infection up to amniocentesis
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Oral valaciclovir (8 g/d) given to pregnant women with a mildly symptomatic fetus
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Valganciclovir given to symptomatic neonates
Number of subjects: 90
Study: 32397821

Group type: EXPERIMENTAL
Intervention: Pika Pamoja (treatment)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 36905345

Group type: EXPERIMENTAL
Intervention: semaglutide 2.4 mg
Number of subjects: 401

Group type: EXPERIMENTAL
Intervention: semaglutide 1.7 mg
Number of subjects: 401

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 401
Study: 32568128

Group type: EXPERIMENTAL
Intervention: Three-dimensional active trunk training exercises using the Space Balance 3D system
Number of subjects: 24

Group type: COMPARATOR
Intervention: General trunk training exercises
Number of subjects: 24
Study: 32347695

Group type: EXPERIMENTAL
Intervention: Vector planning
Number of subjects: 114

Group type: COMPARATOR
Intervention: Manifest refraction (MR) planning
Number of subjects: 114
Study: 35952313

Group type: EXPERIMENTAL
Intervention: Individually tailored lifestyle intervention (n = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional clinical education (n = 60)
Number of subjects: 120
Study: 33854132

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (NMDA receptor antagonist)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Perampanel (AMPA receptor antagonist)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Nimodipine (L-type voltage-gated calcium channel blocker)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 32544109

Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 40
Study: 35893422

Group type: EXPERIMENTAL
Intervention: Mucosal flap on the flap side of the neo-ostium
Number of subjects: 12

Group type: COMPARATOR
Intervention: No mucosal flap on the non-flap side of the neo-ostium
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Post-operative SNOT-22 score
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Post-operative UPSIT score
Number of subjects: 12
Study: 32028996

Group type: EXPERIMENTAL
Intervention: 50 mM Tris‐HCl (pH 7.5) extraction followed by 20% TCA‐acetone precipitation
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Modifications during protein washing, re‐solubilization in rehydration buffer, and isoelectric focusing (IEF)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Mass spectrometry identification of spots from the 2‐DE gel of D. hirsuta
Number of subjects: 3
Study: 34237668

Group type: EXPERIMENTAL
Intervention: Foot reflexology for 12 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Routine treatment and follow-up (Control)
Number of subjects: 48
Study: 33157912

Group type: EXPERIMENTAL
Intervention: Value-based rational emotive behavior programme (V-REBP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 35792064

Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy (200 mg Q3W for up to 35 cycles + chemotherapy: paclitaxel 175 mg/m2 + cisplatin 50 mg/m2 or carboplatin AUC 5)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo plus chemotherapy (same chemotherapy regimen)
Number of subjects: 57
Study: 33849844

Group type: EXPERIMENTAL
Intervention: Alirocumab 150 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ezetimibe 10 mg/day
Number of subjects: 60
Study: 32357944

Group type: EXPERIMENTAL
Intervention: Low-aflatoxin pre-blended porridge flour (maize and groundnut in a 4:1 ratio) and low-aflatoxin groundnut flour, provided to the intervention group starting at 6 months of age.
Number of subjects: 3120

Group type: COMPARATOR
Intervention: Low-aflatoxin pre-blended porridge flour and low-aflatoxin groundnut flour promoted through education but acquired by the household in the control group.
Number of subjects: 3120

Group type: EXPERIMENTAL
Intervention: Intervention group (low-aflatoxin diet)
Number of subjects: 3120

Group type: COMPARATOR
Intervention: Control group (education on the same porridge mix and groundnut flour)
Number of subjects: 3120
Study: 34343623

Group type: EXPERIMENTAL
Intervention: Preoperative lateral quadratus lumborum block (40 mL, ropivacaine 0.25%)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Preoperative lateral quadratus lumborum block
Number of subjects: 46
Study: 32940786

Group type: EXPERIMENTAL
Intervention: Rhythmic Auditory Stimulation (RAS) at fast tempo (120% of normal tempo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Rhythmic Auditory Stimulation (RAS) at normal tempo
Number of subjects: 60

Group type: COMPARATOR
Intervention: Psychiatrically healthy individuals
Number of subjects: 60
Study: 32932051

Group type: EXPERIMENTAL
Intervention: SAMP test with ½kg weight
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: SAMP test with 1kg weight
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: SAMP test with 1½kg weight
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: SAMP test overall
Number of subjects: 70
Study: 35020888

Group type: EXPERIMENTAL
Intervention: Azithromycin treatment
Number of subjects: 0
Study: 33955088

Group type: EXPERIMENTAL
Intervention: Vision-based speed of processing training (VSOP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Mental leisure activities (MLA)
Number of subjects: 0
Study: 35083545

Group type: EXPERIMENTAL
Intervention: Patient Concerns Inventory
Number of subjects: 92

Group type: COMPARATOR
Intervention: Standard care (systematic questioning approach)
Number of subjects: 92
Study: 33636401

Group type: EXPERIMENTAL
Intervention: Transcranial laser stimulation (1064-nm wavelength laser, power density: 250 mW/cm2)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 68
Study: 32694245

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 178
Study: 35071605

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 37
Study: 34689783

Group type: EXPERIMENTAL
Intervention: Universal test and treat (UTT) strategy access
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control communities without access to UTT
Number of subjects: 71
Study: 34195765

Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia with postoperative epidural analgesia
Number of subjects: 1802

Group type: COMPARATOR
Intervention: General anesthesia with postoperative intravenous analgesia
Number of subjects: 1802

Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia
Number of subjects: 1802

Group type: COMPARATOR
Intervention: General anesthesia
Number of subjects: 1802
Study: 32001384

Group type: EXPERIMENTAL
Intervention: ABM/P-15 (mixed 50/50, 5cc/level)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Allograft bone (30 g/level)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: ABM/P-15 and Allograft
Number of subjects: 101
Study: 33838348

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 420

Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 420
Study: 32008619

Group type: EXPERIMENTAL
Intervention: Simulator-based TEE training
Number of subjects: 71

Group type: COMPARATOR
Intervention: Web-based TEE training
Number of subjects: 71
Study: 35315885

Group type: EXPERIMENTAL
Intervention: Prophylactic 40% dextrose gel (n=681)
Number of subjects: 1359

Group type: COMPARATOR
Intervention: Placebo gel (n=678)
Number of subjects: 1359

Group type: EXPERIMENTAL
Intervention: Prophylactic 40% dextrose gel
Number of subjects: 1359

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 1359
Study: 34201703

Group type: EXPERIMENTAL
Intervention: Whey protein isolate
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Rice protein isolate
Number of subjects: 9

Group type: COMPARATOR
Intervention: Potato protein isolate
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All proteins
Number of subjects: 9
Study: 33053024

Group type: EXPERIMENTAL
Intervention: Standard treatment plus dexamethasone (20mg IV once daily for 5 days, then 10mg IV once daily for additional 5 days or until ICU discharge)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Standard treatment without dexamethasone (Control Group)
Number of subjects: 350
Study: 33712022

Group type: EXPERIMENTAL
Intervention: Eat Well @ IGA intervention (trolley and basket signage, local area and in-store promotion, shelf tags for healthiest packaged foods)
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Staff perceptions of the Eat Well @ IGA intervention
Number of subjects: 500

Group type: EXPERIMENTAL
Intervention: Stakeholder collaboration in intervention design and implementation
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (wait-listed stores)
Number of subjects: 500
Study: 33087372

Group type: EXPERIMENTAL
Intervention: Urban school children
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Rural school children
Number of subjects: 854

Group type: EXPERIMENTAL
Intervention: Overall school children
Number of subjects: 854

Group type: COMPARATOR
Intervention: Place of residence (urban vs rural)
Number of subjects: 854
Study: 35883180

Group type: EXPERIMENTAL
Intervention: Individualized blood pressure management (MAP maintained within 10% of the first MAP measured before EVT)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Standard blood pressure management (SBP maintained within 140-180 mm Hg until reperfusion or artery closure)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Individualized blood pressure management
Number of subjects: 432
Study: 32335963

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Public Transportation/Active Commuting (IG-PT, N = 25)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Cycling (IG-C, N = 26)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control Group (CG, N = 22)
Number of subjects: 73
Study: 35130299

Group type: EXPERIMENTAL
Intervention: VE (Violence prevention + Education)
Number of subjects: 2075

Group type: EXPERIMENTAL
Intervention: VEHW (Violence prevention + Education + Health + Wealth)
Number of subjects: 2075

Group type: COMPARATOR
Intervention: V-only (Violence prevention only)
Number of subjects: 2075
Study: 32790868

Group type: EXPERIMENTAL
Intervention: Effect size Correlation for COnfounding determination (ECCO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard approach for determining optimal number of PEER factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ECCO
Number of subjects: 0
Study: 35598000

Group type: EXPERIMENTAL
Intervention: Structured educational intervention based on the rational perception of postoperative pain and discomfort (anchoring and improved pain scale), and the proper use of analgesics
Number of subjects: 414

Group type: COMPARATOR
Intervention: Standard information on post-discharge pain management
Number of subjects: 414
Study: 33723790

Group type: EXPERIMENTAL
Intervention: Synolis VA (80 mg hyaluronic acid and 160 mg sorbitol)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Synvisc-One (48 mg hylan GF-20)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Synolis VA
Number of subjects: 202

Group type: COMPARATOR
Intervention: Synvisc-One
Number of subjects: 202
Study: 33989539

Group type: EXPERIMENTAL
Intervention: Tri-antigenic hepatitis B vaccine (TAV) - 10 μg, administered intramuscularly on days 0, 28, and 168.
Number of subjects: 1607

Group type: COMPARATOR
Intervention: Mono-antigenic hepatitis B vaccine (MAV) - 20 μg, administered intramuscularly on days 0, 28, and 168.
Number of subjects: 1607
Study: 33374575

Group type: EXPERIMENTAL
Intervention: Topical gel containing diclofenac sodium, methyl salicylate, and lyophilized Calendula officinalis
Number of subjects: 115
Study: 34082075

Group type: EXPERIMENTAL
Intervention: Daily self-weighing (DSW) with instruction to weigh daily and provision of a web-enabled digital scale with graphical weight feedback
Number of subjects: 400

Group type: COMPARATOR
Intervention: Standard Care (receive a monetary gift card equivalent to value of the scale)
Number of subjects: 400